Home

Saroja Pharma Industries India Ltd EPS

Image

Saroja Pharma Industries India Ltd

NSE: SarojaPharmaIn

EPS

₹ 2.18

Last updated on: May 09, 2025

Key Highlights

  • The Earning per Share of Saroja Pharma Industries India Ltd is ₹ 2.18 as of 09 May 25 .

Historical P/B Ratio of Saroja Pharma Industries India Ltd

No data available

Company Fundamentals for Saroja Pharma Industries India Ltd

Market Price of Saroja Pharma Industries India Ltd

1M

1Y

3Y

5Y

Monitoring Saroja Pharma Industries India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 May 202539.1
08 May 202542.35
07 May 202542.35
06 May 202545
05 May 202545
02 May 202539.65
30 Apr 202538.65
28 Apr 202538
25 Apr 202538
24 Apr 202535.8

SWOT Analysis Of Saroja Pharma Industries India Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Saroja Pharma Industries India Ltd

Asset Value vs Market Value of Saroja Pharma Industries India Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Market Cap of Saroja Pharma Industries India Ltd

No data available

* All values are in crore

Historical Revenue of Saroja Pharma Industries India Ltd

No data available

* All values are in crore

Historical EBITDA of Saroja Pharma Industries India Ltd

No data available

* All values are in crore

Historical Net Profit of Saroja Pharma Industries India Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Saroja Pharma Industries India Ltd News Hub

Saroja Pharma Industries India schedules AGM

Saroja Pharma Industries India announced that the 6th Annual General Meeting (AGM) of the company wi

Read more

10 Sept 24

Saroja Pharma Industries India schedules board meeting

Saroja Pharma Industries India will hold a meeting of the Board of Directors of the Company on 13 No

Read more

12 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Saroja Pharma Industries India Ltd

What is the EPS of Saroja Pharma Industries India Ltd stock?

The Earnings Per Share (EPS) of Saroja Pharma Industries India Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Saroja Pharma Industries India Ltd EPS calculated?

The EPS of Saroja Pharma Industries India Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Saroja Pharma Industries India Ltd report its EPS?

Saroja Pharma Industries India Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Saroja Pharma Industries India Ltd EPS?

Factors that influence the EPS of Saroja Pharma Industries India Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Saroja Pharma Industries India Ltd EPS growth indicate future performance?

Yes, consistent growth in Saroja Pharma Industries India Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions